Allon Therapeutics Inc.
NPCUF
$0.0001
$0.000.00%
OTC PK
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -1.06M | -7.11M | -1.86M | -3.21M | -2.77M |
| Total Depreciation and Amortization | 1.50K | 110.80K | 128.80K | 128.30K | 130.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.60K | 4.02M | 95.10K | 215.40K | 129.80K |
| Change in Net Operating Assets | 255.90K | 980.60K | -1.16M | 770.20K | 119.90K |
| Cash from Operations | -773.50K | -2.00M | -2.79M | -2.10M | -2.39M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 2.47M |
| Total Debt Repaid | -- | 0.00 | 0.00 | -2.50M | -- |
| Issuance of Common Stock | -- | 131.20K | 0.00 | 9.50M | 498.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 5.90K | -582.50K | -3.70K |
| Cash from Financing | -- | 132.30K | 5.90K | 6.35M | 2.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | -- | -- | -- |
| Net Change in Cash | -773.50K | -1.86M | -2.78M | 4.26M | 565.70K |